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Introduction
For over 3 decades lung transplantation has remained the only viable option for many types of  end-stage 
pulmonary diseases. Despite advances in surgical and postoperative management techniques the medium 
survival after lung transplant significantly lags behind other solid-organ recipients at approximately 5.8 
years (1). A major limitation to recipient survival is bronchiolitis obliterans syndrome (BOS), the most 
common form of  chronic lung allograft dysfunction (CLAD) (2). BOS is diagnosed by the loss of  forced 
expiratory volume to the exclusion of  other causes of  pulmonary dysfunction such as infection, acute rejec-
tion, or anastomotic complications. BOS severity is driven by the progression of  obliterans bronchiolitis 
(OB), inflammatory fibrotic eruptions that partially or completely obstruct the distal bronchioles (1).
Club cells are nonciliated epithelial secretory cells that are highly prevalent in the pulmonary distal bron-
chioles in both humans and mice (3). They are often identified by the expression of  Scgb1a1, which encodes 
the club cell secretory protein (CCSP, CC10), a 16-kDa peptide with reported antiinflammatory properties 
that coats airway surfaces (4). Club cells help maintain small airway homeostasis through detoxifying xeno-
biotic and oxidizing molecules, secretion of  antimicrobial peptides, and promotion of  mucociliary clearance. 
They also play a key role in bronchiolar epithelial repair through their ability to self-renew and differentiate 
into ciliated and goblet cells (5). In line with these observations, several studies have shown that targeted club 
cell ablation delays or prevents epithelial repair (6, 7). Interestingly, many nonalloimmune stressors of  airway 
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demonstrate a vital role for club cells in maintaining lung transplant tolerance and propose a model 
to identify the underlying mechanisms of OB.
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epithelium are risk factors for BOS development, which include primary graft dysfunction (8), Pseudomonas 
aeruginosa infection (9), community-acquired respiratory viral infections (10), and chronic aspiration of  gas-
tric acid (11, 12). There are also a few reports demonstrating club cell injury in lungs with BOS. For example, 
low CCSP levels in bronchiolar lavage fluid have been reported either as a risk factor for, or associated with, 
BOS development (13, 14). More recently, Palmer and colleagues demonstrated that patients with BOS have 
diminished CCSP expression in the airway epithelial cells of  their terminal bronchioles (15). However, it 
remains to be investigated whether club cell loss is sufficient to trigger OB pathogenesis and promote immune 
responses known to be associated with BOS risk.
Here, we describe a mouse orthotopic lung transplant (OLT) model that generates OB lesions in 
response to bronchiolar epithelial injury generated through the conditional activation of  transgenes that 
direct club cell ablation. Club cell loss leads to the augmentation of  adaptive immune responses that are 
coupled to BOS risk. Additionally, we find that CD8+ T cells play an important role in inhibiting club cell 
maintenance and proliferation.
Results
Club cell ablation triggers OB pathogenesis in lung transplant allografts. To determine if  the loss of  club cells 
promotes OB, we utilized triple-transgenic (3T) mice bearing the following genes: a reverse tetracycline 
activator gene driven by the CCSP promoter, Cre recombinase gene under control of  the reverse tetracy-
cline activator, and a lox-P–activated diphtheria toxin A gene (DT-A). Ingestion of  doxycycline by 3T mice 
induces Cre-mediated recombination of  the lox-P DT-A locus that promotes DT expression specifically in 
CSSP-expressing cells, resulting in their depletion and consequential injury to the bronchiolar epithelium 
(6). Because 3T mice were originally developed on a mixed histocompatibility antigen background, we 
extensively backcrossed these mice with FVB and C57BL/6 (B6) mice to generate fully defined minor and 
major histocompatibility 3T FVB and 3T B6 strains for syngeneic and allogeneic transplantation. To induce 
allograft acceptance in 3T FVB → B6 lung recipients, we administered CD40L-neuralizing (CD40L is also 
known as CD154) antibodies (Abs) and the CD80/86 antagonist CTLA4Ig (Figure 1A), which we have 
previously demonstrated induces established tolerance in the mouse OLT model 3 days after transplant 
(16). To implement club cell depletion, 3T B6 → B6 (syngeneic) and 3T FVB → B6 (allogeneic) recipient 
mice ingested doxycycline between postoperative day (POD) 7 and POD 9.5. Immunohistochemical anal-
ysis of  syngeneic and allogeneic transplants on POD 11 revealed small airways denuded of  CCSP+ cells, 
but with the preservation of  cells that expressed acetylated α-tubulin (Ac-tubulin), a marker for ciliated cells 
(Figure 1, B and C). By POD 16, however, syngeneic recipients had repaired their bronchiolar epithelium, 
as evident by reconstituted club and ciliated cell luminal monolayers that resembled preinjured bronchi-
oles. In contrast, allografts contained club cells predominantly arranged in nonluminal monolayers without 
intervening ciliated cells. Additionally, many bronchioles had sharply reduced or completely absent lumi-
nal expression of  Ac-tubulin, although scattered ciliated cells could be detected throughout the interstitium 
(Supplemental Figure 1; supplemental material available online with this article; https://doi.org/10.1172/
jci.insight.124732DS1). Histological assessment of  POD 16, 3T FVB → B6 recipients that underwent club 
cell ablation revealed high-grade inflammatory bronchiolar injury and severe obliterative disease (Figure 
2, A–C). In contrast, analogously treated syngeneic lung transplants had at most mild graft inflammation, 
and lacked OB or peribronchial lesions up to POD 30 (Supplemental Figure 2). Total collagen deposition, 
which can be assessed by hydroxyproline assay or visualized by Masson’s trichrome stain, is promoted 
by chronic airway injury and accumulates to a higher degree in BOS patients when compared with stable 
lung recipients (17). Hydroxyproline accumulation was significantly greater in allografts with OB when 
compared with syngeneic transplants that underwent club cell ablation (Figure 2D). Masson’s trichrome 
staining of  allograft OB lesions also revealed collagen deposition within transluminal fibrotic lesions (Fig-
ure 2E). Finally, we did not observe the generation of  OB lesions in allograft recipients following treatment 
with naphthalene (Supplemental Figure 3), an agent that has been used to ablate club cells (18) but may 
possibly inhibit lymphocyte activation (19).
Previous work has demonstrated that club cells can be defined as pulmonary-restricted CD45–CD34–
CD31–EpCAMhiCCSPhi cells (20). To further define the dynamics of  bronchiolar epithelial repair in lung 
transplants we performed flow cytometric analysis to quantitate club cell abundance and proliferative 
responses following injury (Figure 3, A–H). In both syngeneic grafts and allografts there was an approx-
imate 80% reduction in club cell abundance when measured 1.5 days after ablation. However, within the 
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Figure 1. Lung allograft recipients are unable to repair their bronchiolar epithelium following club cell depletion. 
(A) A mouse OLT model that generates OB in 16 days. B6 recipients of 3T FVB left lungs treated with CD40L Abs 
(POD 0) and CTLA4Ig (POD 2) to establish tolerance were fed doxycycline by food and water (DOX) from POD 7 to 9.5 
and analyzed for graft inflammation on POD 16. 3T FVB and 3T B6 (B) donor lungs and (C) transplants stained with 
CCSP and Ac-tubulin Abs on POD 7, 11, and 16. Scale bars: 50 μm. Data shown are a representative result from at 
least 3 independent experiments.
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remaining club cell compartment, the number undergoing replication was several-fold higher in synge-
neic grafts when compared with allografts. Additionally, on POD 16, syngeneic grafts had nearly 3-fold 
more club cells relative to allografts. Therefore, club cell regenerative responses are sharply blunted in lung 
allografts that develop OB.
Club cell ablation stimulates adaptive immune responses to lung transplants. We next determined if  club cell 
depletion leads to a loss of  immune tolerance. To this end, we compared effector T cell responses in 3T 
FVB allografts to double-transgene (2T FVB) allografts that lack the lox-P–activatable DT-A gene and 
therefore do not develop OB (Supplemental Figure 4). 3T and 2T FVB allograft recipients had comparable 
numbers of  intragraft CD4+ T cells, Foxp3+CD4+, and IFN-γ+CD4+ T cells on POD 16 (Figure 4, A and B). 
However, club cell ablation led to greater accumulation of  IL-17A+CD4+, total CD8+, and IFN-γ+CD8+ T 
cells within 3T FVB allografts. Additionally, specifically within airspaces of  3T FVB allografts, there was 
greater than a 3-fold increase of  IFN-γ+CD8+ T cells (Figure 4C). The development de novo donor-anti-
gen-specific Abs (DSAs) is a reported risk factor for BOS development (21). We therefore asked if  club cell 
ablation promotes the accumulation of  Abs that recognize FVB antigens (Figure 4D). When compared 
with recipients of  2T FVB allografts, there were significantly greater amounts of  DSA against FVB anti-
gens in the peripheral blood of  3T FVB allograft recipients.
Because BOS progression is reportedly coupled to the loss of  tolerance to alloantigens and the pulmo-
nary self-restricted antigens, collagen V (ColV) and K-α1 tubulin (Kα1T) (22–24), we next assessed T cell 
antigen specificity through performing antigen recall assays on CD4+ and CD8+ T cells isolated from POD 
16 lung transplants (Figure 5A). Challenge of  3T FVB allograft CD4+ T cells with donor antigen-presenting 
cells (APCs) generated significantly higher amounts of  IL-17A but not IFN-γ production relative to CD4+ 
T cells from 2T FVB allografts. Syngeneic APCs bearing ColV or Kα1T peptides also stimulated higher 
amounts of  IL-17A from 3T FVB allograft CD4+ T cells compared with those from 2T FVB allograft 
CD4+ T cells. Despite the lack of  overall expansion of  intragraft IFN-γ +CD4+ T cells there was a small but 
significant augmentation of  IFN-γ production following ColV stimulation. In addition, club cell ablation 
led to more IFN-γ production from 3T FVB allograft CD8+ T cells following stimulation with donor anti-
gens or self-antigens. In line with these observations, allografts with OB had accumulated higher intragraft 
ColV mRNA and protein along the epithelial basement membrane and within OB lesions (Figure 5, B–D). 
Together, these results demonstrate that club cell depletion induces the loss of  tolerance to donor and pul-
monary self-restricted antigens in lung transplants.
Alloantigen-primed CD8+ T cells inhibit club cell regenerative responses. T cells are required for lung allograft 
rejection (25), but whether they regulate reparative responses by club cells remains unknown. Accordingly, 
we examined the role of  T cells in our OB model by utilizing Ab-mediated T cell depletion (Figure 6, A–C, 
and Supplemental Figure 5). Pan–T cell depletion greatly reduced epithelial inflammation and eliminated 
OB lesions in 5 out of  7 allografts. Pan–T cell depletion also resulted in the repopulation of  bronchiolar 
epithelium with club and ciliated cells (Figure 6D). Additionally, club cell proliferative responses were 
sharply elevated over recipients that received control Abs (Figure 6, E and F). Because we observed the high 
accumulation of  airspace-resident effector CD8+ T cells in lung allografts with OB we next tested the effects 
of  CD8-depleting Ab administration to recipients (Figure 7, A–F). Like pan–T cell depletion, CD8+ T cell 
depletion improved club cell regenerative responses and prevented OB lesion generation. In contrast, OB 
development was unaffected by Ab-mediated CD4+ T cell depletion (Supplemental Figure 6). To further 
examine the effects of  CD8+ T cells on epithelial injury we cocultured club cells with alloantigen-primed, 
unprimed allogeneic, or syngeneic CD8+ T cells (Figure 8, A–C). Only alloantigen-primed CD8+ T cells 
inhibited club cell proliferation and maintenance. Noting our previous observations that apical surface 
MHC class I expression on airway epithelial cells is recognized by allogeneic CD8+ T cells (26), we asked if  
a neutralizing Ab that recognizes 1 of  3 MHC class I alleles (H-2Kq) expressed by FVB mice (27) prevents 
CD8+ T cell–mediated inhibition of  club cell maintenance (Figure 8D). Blockade of  H-2Kq significantly 
improved club cell maintenance, indicating that direct interactions between airway-infiltrating CD8+ T cells 
and club cells prevent bronchial epithelial repair in lung allografts.
Discussion
In the model of  mouse orthotopic lung allograft transplantation reported in this study, we show that acute 
epithelial injury mediated by the ablation of  club cells is sufficient to cause OB. The depletion and regener-
ation of  the club cell compartment was assessed by immunohistochemistry and flow cytometric analysis. 
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Figure 2. Club cell ablation leads to severe OB lesions in lung allografts. (A) H&E histological staining of indicated 
POD 16 transplants treated with or without DOX and blindly scored for (B) airway inflammation (B score) where 0 
= none, 1R = low grade, 2R = high grade, and X = ungradable, and (C) the presence (1) or absence (0) of OB lesions 
(C score). Dot plots represent mean score ± SEM of individual data obtained from 5 to 10 transplanted mice per 
group. (D) Hydroxyproline content and (E) Masson’s trichrome staining of indicated transplant tissue at POD 16. 
Data shown in D represent mean ± SEM (N ≥ 4/group). **P < 0.01, ***P < 0.001 by 2-tailed Mann-Whitney U test. 
Images in A and E are representative histology from at least 5 transplants. Scale bars: 500 μm (upper images in 
both) or 50 μm (lower images).
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Given CCSP expression within epithelial progenitor pools, the latter approach allowed us to more pre-
cisely monitor the regenerative dynamics of  club cells through the use of  lineage-specific markers and 
intracellular CCSP expression (7, 20). Irrespective of  whether the donor lung was on a B6 or FVB back-
ground we observed an average 80% reduction in club cells 1.5 days after doxycycline ingestion, indicating 
there was not a strain-specific induction of  bronchiolar epithelial injury. Another approach to ablate club 
cells is through the systemic administration of  naphthalene, which causes the production of  cytotoxic 
metabolites via oxidation by cytochrome P450 2F2, a monooxygenase that is expressed in club cells (28). 
Naphthalene administration to our model was ineffective at producing OB lesions. Although the reasons 
for this are not clear, it has been reported that toxic naphthalene metabolites generated by the liver inhibit 
Figure 3. Club cell regenerative responses are suppressed in lung allografts. (A) FACS gating strategy for the identifi-
cation of club cells. Data shown are contour plots from a 3T FVB donor lung just prior to transplantation. 3T B6 and 3T 
FVB transplants analyzed at indicated time points and assessed for club cell percentage abundance and proliferation 
(Ki67). (B) Representative contour blots and histograms from at least 4 transplants. (C) Percentage reduction of club 
cell abundance assessed on POD 11 calculated relative to levels prior to ablation on POD 7. (D) Percentage recovery of 
the club cell compartment assessed on POD 16 calculated relative to levels prior to ablation on POD 7. (E) Total number 
of intragraft club cells on POD 16. Club cell proliferation is shown as percentage abundance on (F) POD 11, (G) POD 16, or 
as a total number on (H) POD 16. Dot plots represent mean ± SEM (N ≥ 4/group). n.s., not significant. *P < 0.05, **P < 
0.01, ***P < 0.001 by 2-tailed Mann-Whitney U test.
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Ab production by plasma cells (19). Of  note, in a new mouse OLT model of  lymphocytic bronchitis, B 
cell deficiency protected allografts from club cell loss (29). Given that we observed DSA generation in our 
model, these observations collectively raise the possibility that naphthalene prevents a B cell–dependent 
response that promotes OB. Nevertheless, similar to reports of  naphthalene-mediated club cell depletion, 
we observed the transient spreading of  ciliated cells around denuded bronchioles and the retention of  a 
population of  injury-resistant club cells with high proliferative capacity (20, 30). This was most evident in 
the high number of  proliferating club cells within transplants approximately 2 days after injury induction. 
Moreover, the relative abundance of  proliferating club cells was nearly 3-fold lower in allografts when 
compared with syngeneic grafts, indicating there is a critical threshold of  regenerative capacity required to 
adequately repair the bronchiolar epithelium.
Figure 4. Club cell ablation promotes intragraft effector T cell accumulation and DSA. B6 recipients of 2T FVB and 
3T FVB allografts that received DOX were analyzed by FACS on POD 16 for indicated intragraft T lymphocytes. (A) 
Representative contour plots showing percentage abundance of graft-infiltrating effector T cells from B. (B) T lym-
phocyte numbers are shown for each transplant and as a mean per group ± SEM (N = 6 /group). *P < 0.05 by 2-tailed 
Mann-Whitney U test. (C) Percentage abundance of airway-infiltrating effector T cells. Contour plots are a represen-
tative result from 3 transplants per group. (D) POD 16 recipient serum from 2T and 3T FVB recipients was coincubated 
with FVB thymocytes at indicated dilution ratios and assessed for DSA with anti–mouse IgM antibodies. Reactivity is 
shown as fold mean fluorescence intensity (MFI) relative to serum reactivity to syngeneic B6 thymocytes. Each data 
point represents a mean from at least 4 recipients per group ± SEM. **P < 0.01 by 2-tailed Mann-Whitney U test.
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Club cell depletion led to the rapid loss of  transplant-antigen-specific tolerance. The precise reasons for 
this observation remain unclear. Interestingly, Stripp and colleagues have shown that mice lacking CCSP 
expression have elevated Toll-like receptor 4 expression in pulmonary macrophages (31), suggesting that club 
cells could also play a regulatory role in preventing innate immune responses within lung transplants. Addi-
tionally, we observed a striking similarity between the pattern of  adaptive immune responses following club 
cell ablation and clinical reports of  lung transplant recipients with BOS. This included the augmentation of  
Figure 5. Loss of allogeneic and pulmonary self-antigen tolerance following club cell ablation. (A) POD 16 intra-
graft CD4+ and CD8+ T cell recall assays for syngeneic (B6) APCs, allogeneic (FVB) APCs, and syngeneic APCs that bear 
Kα1T or ColV peptides as measured by IFN-γ and IL-17A production. Data points shown are responses from individual 
transplants and means per group ± SEM (N ≥ 5/group). (B) Semiquantitative RT-PCR measurements of intragraft ColV 
(Col5a1) and Kα1T (Tuba1b) mRNA shown normalized to β-actin (Actb). Each data point represents a single transplant 
along with a group mean ± SEM (N = 5/group). *P <0.05, **P < 0.01, ***P < 0.001 by 2-tailed Mann-Whitney U test (A 
and B). Representative (N ≥ 3/group ) POD 16 allograft ColV and Kα1T (C) immunochemistry and (D) expression quanti-
tation by staining area. In D, each histogram represents individual measurements from 3 or 4 randomly selected areas 
enriched for bronchioles for at least 3 transplants along with a mean per group ± SEM. ***P < 0.001 by 2-tailed t test.
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Th17-mediated immunity (24), the enhanced recognition of  Kα1T and ColV (23), the development of  DSA 
(21, 22), and high numbers of  effector CD8+ T cells in the airway (32, 33). We also made insights into effector 
T cell activation during OB development. To the best of  our knowledge, this is the first report of  the existence 
of  Kα1T- and ColV-specific effector CD8+ T cells in lung allografts. We also observed that increases in intra-
graft IL-17A+CD4+ T cells occur without significant changes in the overall number of  graft-resident CD4+ T 
cells. This finding suggests possible de novo generation of  Th17 cells within graft tissue through the recruit-
ment of  an uncommitted or naive CD4+ T cell pool. We have previously demonstrated that the targeted deple-
tion of  lung allograft–resident Foxp3+CD4+ T cells abrogates established tolerance (34). Recent reports have 
Figure 6. Pan–T cell depletion inhibits OB and promotes club cell regenerative responses. 3T FVB → B6 recipients 
that underwent club cell depletion received either control Ig or CD4- and CD8-depleting Abs on POD 6 and POD 11 were 
analyzed on POD 16 for bronchiole injury by (A) H&E and Masson’s trichrome stain, (B) airway inflammation, and (C) OB 
lesion score, or evaluated by immunohistochemistry for (D) bronchiolar epithelial repair with CCSP and Ac-tubulin Abs. 
Transplant club cell (E) total numbers and (F) proliferating numbers (Ki67+) on POD 16. Results shown in A are represen-
tative stains used for grading in B and C, which show mean scores ± SEM (N = 7/group). The insets in A are ×400 (orig-
inal magnification). Scale bars: 500 μm (A) and 50 μm (D). Stains shown in D are representative of 7 transplants and E 
and F show mean numbers ± SEM (N ≥ 4/group). *P < 0.05, **P < 0.01, ***P < 0.01 by 2-tailed Mann-Whitney U test.
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also linked the loss of  peripheral blood Foxp3+CD4+ T cells with increased risk for CLAD (35, 36). Although 
we did not quantitate peripheral circulating Foxp3+CD4+ T cells, there was no significant change in absolute 
numbers within graft tissues. One explanation for this discordant observation is that the ratio of  Foxp3+CD4+ 
T cells to T cell effectors may be a more informative measure than is the assessment of  absolute numbers (37). 
Indeed, due to increased Th17 and effector CD8+ T cell numbers, this ratio was sharply lower in allografts 
with OB. The development of  Foxp3+CD4+ T cell regulatory dysfunction may also play an important role in 
allograft rejection (38). Thus, future studies will be required to better understand the role of  Foxp3+CD4+ T 
cell abundance and function in OB pathogenesis.
Club cell ablation promoted elevated ColV mRNA and protein expression, which was especially 
evident within the epithelial basement membranes and OB lesions. Of  note, IL-17 has been previously 
Figure 7. CD8+ T cell depletion inhibits OB and promotes club cell regenerative responses. 3T FVB → B6 recipients 
that underwent club cell depletion received either control IgG or CD8-depleting Abs on POD 6 and POD 11 and were 
analyzed on POD 16 for transplant bronchiole injury by (A) H&E and Masson’s trichrome stain, (B) airway inflamma-
tion, and (C) OB lesion score, or evaluated by immunohistochemistry for (D) bronchiolar epithelial repair with CCSP 
and Ac-tubulin Abs. Transplant club cell (E) total numbers and (F) proliferating numbers (Ki67+) on POD 16. Results 
shown in A are representative stains used for grading in B and C, which show mean scores ± SEM (N =5/group). The 
insets in A are ×400 (original magnification). Scale bars: 500 μm (A) and 50 μm (D and insets in A). Stains shown in 
D are representative of 5 transplants and E and F show mean numbers ± SEM (N = 4/group). **P < 0.01, ***P < 0.01 
by 2-tailed Mann-Whitney U test.
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reported to promote ColV overexpression and the development of  OB (39). In line with this previous 
observation we demonstrated that CD4+ T cells isolated from allografts with OB made significantly more 
IL-17A when challenged with ColV peptides when compared with CD4+ T cells isolated from tolerant 
allografts. Despite increased T cell–mediated recognition of  Kα1T we did not detect changes in its expres-
sion following club cell ablation. One possible reason for these differences comes from a recent finding 
that Kα1T protein is highly enriched within exosomes released from human solid organ allografts, includ-
ing chronically rejected lung transplants (40). As exosome protein cargo can be endocytosed and present-
ed by dendritic cells (41), it remains plausible that T cells can be primed for recognition of  Kα1T without 
increased evidence of  expression within parenchymal tissues.
In our model we used a well-established costimulatory blockade regimen (16, 42, 43) to induce lung 
allograft tolerance, which interrupts both CD154/CD40 and B7/CD28 signaling in T cells. CD154 antag-
onism has recognized toxicity in humans due to CD154 expression on activated platelets (44). Also, in a 
mouse heterotopic heart allograft model, the reported mechanism by which costimulatory blockade induc-
es acceptance is through the deletion of  alloreactive T cells (45). In contrast, calcineurin inhibitors are 
thought to promote tolerance by largely inhibiting T cell activation (46). These observations suggest that 
the use of  costimulatory blockade limits the clinical relevance of  our model. However, OB lesions have 
been reported to form spontaneously in about half  of  BALB/c → B6 orthotopic lung transplant recipi-
ents immunosuppressed with cyclosporine and steroids at between 1 and 3 months after engraftment (47). 
Figure 8. Alloantigen-primed effector CD8+ T cells inhibit club cell maintenance and proliferation. Club cells isolated 
by lineage-negative enrichment from FVB lungs were cocultured without (Untreated) or with either unactivated 
syngeneic FVB (Syn), unactivated allogeneic B6 (Unprimed Allo) or alloantigen-primed B6 (Primed Allo) CD8+ T cells, or 
with supernatant from alloantigen-primed B6 CD8+ T cells (Primed Allo Supe). Thirty-six hours later, club cell abundance 
was analyzed and shown as (A) representative contour plots from at least 4 independent experiments, or (B) total 
numbers per experiment with a group mean ± SEM (N ≥ 4/group). Club cells analyzed for proliferation in the presence of 
indicated CD8+ T cells by (C) CFSE dilution shown as a representative histogram from 5 independent experiments along 
with a group mean ± SEM. **P < 0.01, ***P < 0.001 by 2-tailed Mann-Whitney U test (B and C). (D) Club cell numbers 
remaining after coculture with indicated CD8+ T cells in the presence of control IgG or a neutralizing antibody directed 
against the H-2Kq (FVB haplotype) MHC class I protein. Each data point represents a single determination from 4 
independent experiments with a group mean ± SEM. *P < 0.05, **P < 0.01 by unpaired 2-tailed t test. 
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Moreover, despite the use of  costimulatory blockade, we could readily detect intragraft alloreactive T cells 
in 2T FVB recipients, suggesting such clones are not efficiently deleted in lung transplants.
How T cells regulate epithelial cell repair in lung transplants remains an understudied area. This is likely 
due to observations that several CD4+ and CD8+ T cell subsets are required for the induction of  immuno-
suppression-mediated lung allograft tolerance (16, 42, 43). Accordingly, we chose to deplete T cells using 
Abs after the establishment of  tolerance (16), but just prior to the induction of  epithelial injury to study club 
cell responses. We observed that pan–T cell depletion largely reversed the loss of  proliferating club cells, 
restored the club cell compartment, and largely eliminated OB lesions. However, we still noted some epithe-
lial inflammation conceivably caused by the homeostatic expansion of  residual intragraft alloreactive T cells 
(48). We extended these studies to determine whether CD8+ or CD4+ T cells promote OB generation. CD8+ 
T cell depletion led to the promotion of  club cell regenerative responses and protection from OB that was 
comparable to pan–T cell depletion. In contrast, CD4+ T cell depletion had no effect on OB lesion develop-
ment, possibly due to the elimination of  regulatory CD4+ T cells, which are reported to inhibit effector CD8+ 
T cell function in allografts (49, 50). We further explored the role of  CD8+ T cells in OB by coculturing CD8+ 
T cells with club cells. Consistent with our observations of  high numbers of  airway-resident effector CD8+ 
T cells in lung allografts with OB, alloantigen-primed CD8+ T cells inhibited club cell maintenance and pro-
liferation. Additionally, in line with previous findings that airway-resident allogeneic CD8+ T cells recognize 
apical MHC class I expressed on airway epithelium (26), we observed that neutralizing Abs against H-2Kq 
improved club cell maintenance. Whether alloantigen-primed CD8+ T cells kill or suppress the proliferation 
of  club cells was not directly addressed by our studies, but is the subject of  future investigation.
In summary, using a model of  OLT we find that club cell ablation leads to development of  OB and 
the induction of  adaptive immune responses associated with BOS risk. Given that severe and reliable OB 
lesions are generated within 16 days after transplantation, this model should be useful for screening poten-
tial approaches to treating bronchiolar epithelial injury. To that end, our studies advocate for further defin-
ing T cell–dependent pathways that affect club cell regeneration and differentiation to identify new thera-
peutic targets for the prevention of  BOS.
Methods
Mice and OLT. C57BL/6 (B6) and FVB/N (FVB) were purchased from Jackson Laboratories. CCSP rtTA/
TetOCre/DT-A (3T) mice were gifts from Jeffery Whitsett of  The Children’s Hospital of  Cincinnati. 3T 
mice were backcrossed to greater than 99% FVB and C57BL/6 backgrounds, which was confirmed using 
microsatellite-assisted accelerated backcrossing (MAX-BAX, Charles River). Mouse left OLT was conduct-
ed with 8- to 12-week-old donor and recipient mice as previously described by our group (42). To induce 
allograft acceptance, recipients received i.p. 250 μg of  CD40L Abs (MR1) on POD 0 and 200 μg of  mouse 
recombinant CTLA4Ig on POD 2 (16).
Club cell ablation and T cell depletion. Club cell injury was triggered by doxycycline ingestion via food (625 
mg/kg chow, ENVIGO) and water (2 mg/ml, Sigma-Aldrich) from POD 7 to POD 9.5. T lymphocyte cell 
depletion was accomplished by i.p. injection of  anti-CD4 (500 μg GK1.5; Bio X Cell) or anti-CD8 (500 μg, 
53-6.7, Bio-X-Cell) Abs or by using both aforementioned Abs for pan–T cell depletion. We used rat IgG2b 
(clone LTF-2; Bio-X-Cell), rat IgG2a (clone 2A3; Bio-X-Cell), or both Abs for isotype controls for CD4+, 
CD8+, or pan–T depletion, respectively. Abs were administered on POD 6 and 11.
Histological analysis. Harvested grafts were formaldehyde fixed, paraffin embedded, and stained with 
H&E or Masson’s trichrome stain. Lung transplant histology was graded by a blinded pathologist using 
the 2007 revision of  the 1996 working formulation for the standardization of  nomenclature in the diag-
nosis of  lung rejection, where small-airway inflammation is scored Grade B0 (none), Grade B1R (low 
grade), Grade B2R (high grade), and BX (ungradable). OB is graded without regard to inflammation as 
C1 (present) or C0 (absent) (51).
Bronchiolar epithelium paraffin sections were first blocked with 5% goat serum and 2% fish gelatin 
(both from Sigma-Aldrich) at 25°C for 45 minutes. Sections were then stained with 1:500 polyclonal rabbit 
anti–mouse/rat CCSP (Seven Hills Bioreagents) and mouse anti–Ac-tubulin, 1:5000 (6-11B-1, Sigma-Al-
drich) overnight at 4°C. For immunofluorescent visualization, we used goat anti-mouse Alexa Fluor 488–
labeled secondary Ab, 1:1000 (Thermo Fisher Scientific) and goat anti-rabbit Alexa Fluor 555–labeled 
secondary Ab, 1:1000 (Cell Signaling Technology). For ColV and Ka1T immunohistological analysis 
1:100 polyclonal rabbit anti-ColV (Abcam), 1:200 polyclonal rabbit anti-Kα1T (Thermo Fisher Scientific), 
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or polyclonal rabbit IgG Isotype (Abcam) Ab dilutions were used in conjunction with a Vectastain Elite 
System kit (LS Bio) for detection in accordance with the manufacturer’s recommendations. Quantitation 
of  stain was conducted with ImageJ bundled with Java version 1.8.0 (NIH) in which total pixels of  stain 
were assessed outside nuclear areas. For intragraft collagen measurements we used a Hydroxyproline 
Assay Kit (Sigma-Aldrich) in accordance with manufacturer’s recommendations. Briefly, lung tissue was 
extracted for protein with 6.0N HCl for 3 hours at 120°C and then dried at 60°C overnight. Then, 10 μg 
of  protein was assayed for reactivity for oxidized hydroxyproline with 4-(dimethylamino) benzaldehyde, 
which in turn generates colorimetric product that was read by absorbance at 560 nm on a BioTek Synergy 
HTX Microplate Analyzer.
Flow cytometric analysis and antigen recall assays. Lung tissue was minced and digested in RPMI 1640 with 
type 2 collagenase (0.5 mg/ml) (Worthington Biochemical) and 5 units/ml DNAse (Sigma-Aldrich) for 90 
minutes at 37°C and then filtered through a 70-μm cell strainer (Thermo Fisher Scientific) and treated with 
ACK lysing buffer (Worthington Biochemical). Live cell discrimination was conducted with the Zombie 
(Biolegend) fixable dye. Cell surface staining was conducted with the following Abs: CD45 (30-F11, eBio-
science), CD45.2 (104, Biolegend), CD90.2 (53-2.1, eBioscience), CD4 (clone RM4-5, eBioscience), CD8α 
(53-6.7, eBioscience), CD31 (390, Biolegend), CD34 (HM34, Biolegend), and CD326 (G8.8, Biolegend). 
Staining for Foxp3 (FJK-16s, eBioscience), Ki-67 (16A8, Biolegend), and polyclonal rabbit anti–mouse 
CCSP (Seven Hills Bioreagents, catalog WRAB-3950) was conducted with an intranuclear Transcription 
Factor Staining Buffer Kit (Invitrogen) in accordance with the manufacturer’s recommendations. For IFN-γ 
and IL-17A expression, cells were first stimulated with 1 μM ionomycin (Sigma-Aldrich) and 20 ng/ml 
PMA (Sigma-Aldrich) for 3.5 hours with 2 μM Golgi Plug (BD Biosciences) added for the last 3 hours of  
stimulation and stained with anti–IFN-γ (XMG1.2, eBioscience) and anti–IL-17A (TC11-18H10.1, Bioleg-
end) using a Cytofix/Cytoperm kit (BD Biosciences) in accordance with the manufacturer’s recommenda-
tions. For antigen specificity measurements, T cells were fractionated by positive selection using CD4+ or 
CD8+ immunomagnetic bead labeling kits (Miltenyi Biotec) from allograft cell suspensions and cocultured 
at a 3:1 ratio with irradiated T cell–depleted FVB or B6 cell splenocytes for 96 hours pulsed with 0.5 μg/ml 
Kα1T and ColV (obtained from T. Mohannakumar, St. Joseph’s Hospital, Phoenix, Arizona, USA). IFN-γ 
and IL-17A were measured with uncoated ELISA kits from Invitrogen in accordance with the manufactur-
er’s recommendations.
Semiquantitative RT-PCR. Lung tissues were extracted for RNA with an RNAeasy kit (Qiagen) and 
reverse transcribed with the High-Capacity cDNA Reverse Transcription Kit (Thermo Fisher Scien-
tific). Transcripts were semiquantified with PrimePCR Syber Green Assay (Bio-Rad) kits for Col5a1 
(qMmuCED0046279), Tuba1b (qMmuCED0040564), and Atcb (qMmuCED0027505) in accordance with 
the manufacturer’s recommendations.
Club cell enrichment and culture with CD8+ T cells. FVB lung tissue cell isolates were prepared as described 
for FACS preparation and incubated with biotin-conjugated Abs (all from eBioscience) specific for CD45.1 
(clone A20), CD34 (clone RAM34), CD31 (clone MEC13.3), CD90.1 (clone HIS51), and CD15 (clone 
mc-480), washed, and then labeled with anti-biotin MicroBeads (Miltenyi Biotec) for negative selection on LS 
columns (Miltenyi Biotec). Remaining cells were then incubated with biotin-conjugated CD326 Abs (clone 
caa7-9G8, Miltenyi Biotec), washed, and then labeled anti-biotin MicroBeads for positive selection on an 
MS column (Miltenyi Biotec). Enriched club cell fractions were resuspended in MTEC/Plus medium (52) 
and seeded at 3.3 × 104 cells per well in flat-bottom 96-well tissue culture plates (Thermo Fisher Scientific) 
coated with 50 μg/ml type I rat tail collagen (Becton Dickinson). For proliferation analysis, club cells were 
stained with 10 μM CFSE (Thermo Fisher Scientific) prior to seeding. CD8+ T cells were isolated from B6 or 
FVB resting mouse spleens using CD8+ immunomagnetic bead labeling kits (Miltenyi Biotec) in accordance 
with the manufacturer’s recommendations. To prime CD8+ T cells with alloantigen, T cell–depleted CD45.1+ 
FVB splenocytes were cocultured with B6 CD8+ T cells at a 3 to 1 respective ratio with 100 ng/ml LPS for 72 
hours, which was used to augment alloantigen presentation. Alloantigen-primed CD8+ T cells were removed 
from cultures by using immunomagnetic bead positive selection conducted with biotin-conjugated CD45.2 
Abs (clone A20, eBioscience), anti-biotin MicroBeads, and LS columns. CD8+ T cells (1 × 105) were added 
to each club cell culture well for 24 hours. For proliferation analysis, CD8+ T cells were cocultured with 
CFSE-labeled club cells for 36 hours. Four or 5 wells were used for each test condition. For MHC class I 
blockade experiments 10 μg/ml of  neutralizing Abs against H-2Kq (clone Y-3, Bio-X-Cell) or IgG2b isotype 
control (clone MPC-11, Bio-X-Cell) was added to cultures 1 hour prior to the placement of  CD8+ T cells. 
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Club cells were released from plates using 0.05% trypsin (Thermo Fisher Scientific), washed, and then ana-
lyzed on a Zombie–CD45–CD31–CD34–CD326+CCSP+ gate using Countbright beads (Thermo Fisher Scien-
tific) for quantitative FACS analysis.
Statistics. Unless indicated, a 2-tailed Mann–Whitney U test was performed to assess statistical rele-
vance using GraphPad Prism version 7.0. P < 0.05 was considered significant. n.s., not significant.
Study approval. Animal experiments were conducted in accordance with an approved Washington Uni-
versity Animal Care and Use Committee protocol (number 20160212).
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